Association between Radiologists' Experience and Accuracy in Interpreting Screening Mammograms

por Molins, Eduard, Macià, Francesc, Ferrer, Francesc, Maristany, Maria-Teresa, Castells, Xavier
Publicado 2008

Long-term costs of colorectal cancer treatment in Spain

por Corral, Julieta, Castells, Xavier, Molins, Eduard, Chiarello, Pietro, Borras, Josep Maria, Cots, Francesc
Publicado 2016

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (A...

por Bateman, Eric D., Chapman, Kenneth R., Singh, Dave, D’Urzo, Anthony D., Molins, Eduard, Leselbaum, Anne, Gil, Esther Garcia
Publicado 2015

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptom...

por Sethi, Sanjay, Kerwin, Edward, Watz, Henrik, Ferguson, Gary T, Mroz, Robert M, Segarra, Rosa, Molins, Eduard, Jarreta, Diana, Garcia Gil, Esther
Publicado 2019

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

por Singh, Dave, D’Urzo, Anthony D, Donohue, James F, Kerwin, Edward M, Molins, Eduard, Chuecos, Ferran, Ribera, Anna, Jarreta, Diana
Publicado 2019

The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants

por Li, Weimin, Daoud, Sami Z, Trivedi, Roopa, Lukka, Pradeep B, Jimenez, Eulalia, Molins, Eduard, Stewart, Catherine, Bharali, Pranob, Garcia-Gil, Esther
Publicado 2023

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multi...

por Singh, Dave, Jones, Paul W, Bateman, Eric D, Korn, Stephanie, Serra, Cristina, Molins, Eduard, Caracta, Cynthia, Gil, Esther Garcia, Leselbaum, Anne
Publicado 2014

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

por Watz, Henrik, Troosters, Thierry, Beeh, Kai M, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Notari, Massimo, Zapata, Antonio, Jarreta, Diana, Garcia Gil, Esther
Publicado 2017

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

por D’Urzo, Anthony D, Singh, Dave, Donohue, James F, Kerwin, Edward M, Ribera, Anna, Molins, Eduard, Chuecos, Ferran, Jarreta, Diana, Gil, Esther Garcia
Publicado 2019

An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obs...

por Zhang, Hong, Daoud, Sami Z., Gillen, Michael S., Calderon, Natalia, Heijer, Maria, Molins, Eduard, Garcia-Gil, Esther, Chen, Hong, Li, Qianqian, Liu, Chengjiao, Ding, Yanhua
Publicado 2022

Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study

por Koopman, Maud, Franssen, Frits M E, Gaffron, Swetlana, Watz, Henrik, Troosters, Thierry, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Moya, Miguel, van Burk, Lindy, Maier, Dieter, Garcia Gil, Esther, Wouters, Emiel F M, Vanfleteren, Lowie E G W, Spruit, Martijn A
Publicado 2022